Literature DB >> 32669926

Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China.

L Sun1, Y Xu1, T Zhang1, Y Yang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32669926      PMCID： PMC7339841          DOI： 10.3747/co.27.6529

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  18 in total

1.  3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.

Authors:  Timothy Iveson; Kathleen A Boyd; Rachel S Kerr; Jose Robles-Zurita; Mark P Saunders; Andrew H Briggs; Jim Cassidy; Niels Henrik Hollander; Josep Tabernero; Andrew Haydon; Bengt Glimelius; Andrea Harkin; Karen Allan; John McQueen; Sarah Pearson; Ashita Waterston; Louise Medley; Charles Wilson; Richard Ellis; Sharadah Essapen; Amandeep S Dhadda; Mark Harrison; Stephen Falk; Sherif Raouf; Charlotte Rees; Rene K Olesen; David Propper; John Bridgewater; Ashraf Azzabi; David Farrugia; Andrew Webb; David Cunningham; Tamas Hickish; Andrew Weaver; Simon Gollins; Harpreet Wasan; James Paul
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

2.  Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.

Authors:  Xu Wang; Xiaoxi Zhang; Jiangjiang He
Journal:  Biosci Trends       Date:  2020-02-17       Impact factor: 2.400

3.  Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.

Authors:  Elizabeth M Cespedes Feliciano; Valerie S Lee; Carla M Prado; Jeffrey A Meyerhardt; Stacey Alexeeff; Candyce H Kroenke; Jingjie Xiao; Adrienne L Castillo; Bette J Caan
Journal:  Cancer       Date:  2017-09-07       Impact factor: 6.860

Review 4.  Making sense of adjuvant chemotherapy in colorectal cancer.

Authors:  Gloria H J Chan; Cheng E Chee
Journal:  J Gastrointest Oncol       Date:  2019-12

5.  Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.

Authors:  Dimitrios Pectasides; Vasilios Karavasilis; George Papaxoinis; Georgia Gourgioti; Thomas Makatsoris; Georgia Raptou; Eleni Vrettou; Joseph Sgouros; Epaminontas Samantas; George Basdanis; Pavlos Papakostas; Dimitrios Bafaloukos; Vassiliki Kotoula; Haralambos P Kalofonos; Chrisoula D Scopa; George Pentheroudakis; George Fountzilas
Journal:  BMC Cancer       Date:  2015-05-10       Impact factor: 4.430

6.  Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.

Authors:  Peng Gao; Xuan-Zhang Huang; Yong-Xi Song; Jing-Xu Sun; Xiao-Wan Chen; Yu Sun; Yu-Meng Jiang; Zhen-Ning Wang
Journal:  BMC Cancer       Date:  2018-03-01       Impact factor: 4.430

7.  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.

Authors:  Daniel B Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-02-28       Impact factor: 17.586

8.  Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.

Authors:  Xiao-Wei Xu; Xiao-Xin Wu; Xian-Gao Jiang; Kai-Jin Xu; Ling-Jun Ying; Chun-Lian Ma; Shi-Bo Li; Hua-Ying Wang; Sheng Zhang; Hai-Nv Gao; Ji-Fang Sheng; Hong-Liu Cai; Yun-Qing Qiu; Lan-Juan Li
Journal:  BMJ       Date:  2020-02-19

9.  Colon cancer patients with a serious psychiatric disorder present with a more advanced cancer stage and receive less adjuvant chemotherapy - A Nationwide Danish Cohort Study.

Authors:  Linda Kaerlev; Maria Iachina; Oleg Trosko; Niels Qvist; Pernille Møller Ljungdalh; Bente Mertz Nørgård
Journal:  BMC Cancer       Date:  2018-10-29       Impact factor: 4.430

10.  Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta-analysis.

Authors:  Devon J Boyne; Dylan E O'Sullivan; Emily V Heer; Robert J Hilsden; Tolulope T Sajobi; Winson Y Cheung; Darren R Brenner; Christine M Friedenreich
Journal:  Cancer Med       Date:  2020-01-21       Impact factor: 4.452
View more
  7 in total

1.  Risk factors and clinical outcomes of systemic cancer treatment delays in Filipino patients with solid tumor malignancy during the COVID-19 pandemic: A single tertiary center study.

Authors:  Jessa Gilda Pandy; Omar Maaño; Joanmarie C Balolong-Garcia; Jay T Y Datukan
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-22

Review 2.  Impact of the COVID-19 Pandemic on Colorectal Cancer Diagnosis and Treatment: a Systematic Review.

Authors:  Afrooz Mazidimoradi; Fatemeh Hadavandsiri; Zohre Momenimovahed; Hamid Salehiniya
Journal:  J Gastrointest Cancer       Date:  2021-11-29

3.  Impact of the COVID-19 pandemic on surgical outcomes in patients undergoing colorectal cancer surgery: A retrospective study and meta-analysis of data from 11,082 participants.

Authors:  Gang Tang; Feng Pi; Jie Tao; Zhengqiang Wei
Journal:  Front Public Health       Date:  2022-09-29

4.  The travails of therapeutic modifications in cancer care amidst the COVID-19 pandemic: Future directions and lessons learned.

Authors:  Talal Almas; Muhammad Hassan Naeem Goraya; Zahid Ijaz Tarar; Tarek Khedro; Maryam Ehtesham; Uzair Malik; Abdulla Hussain Al-Awaid; Muhammad Ali Niaz; Lamees Alshaikh; Ali Rifai
Journal:  Ann Med Surg (Lond)       Date:  2021-05-29

5.  Exploring the Safety, Effectiveness, and Cost-Effectiveness of a Chinese Patent Medicine (Fufang E'jiao Syrup) for Alleviating Cancer-Related Fatigue: A Protocol for a Randomized, Double-Blinded, Placebo-Controlled, Multicenter Trial.

Authors:  Zhuo Song; Ling-Yun Sun; Shan-Shan Gu; Xiao-Shu Zhu; He-Zheng Lai; Fang Lu; Ning Cui; Qiong-Yang Li; Yu Wu; Yun Xu
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

6.  Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer.

Authors:  Konstantinos Kamposioras; Kok Haw Jonathan Lim; Joseph Williams; Mohammed Alani; Jorge Barriuso; Joanne Collins; Kalena Marti; Michael Braun; Saifee Mullamitha; Jurjees Hasan; Nooreen Alam; Sophina Mahmood; Spencer Finch; Lauren Bayles; Jennifer King; Mark Saunders
Journal:  Clin Colorectal Cancer       Date:  2021-12-01       Impact factor: 4.035

7.  Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study.

Authors:  Monica Tang; Benjamin Daniels; Maria Aslam; Andrea Schaffer; Sallie-Anne Pearson
Journal:  Lancet Reg Health West Pac       Date:  2021-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.